LNTH
Lantheus Holdings
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
LNTH Profile
Lantheus Holdings, Inc.
A company that develops diagnostic medical imaging agents and products for the diagnosis of cardiovascular and other diseases
Healthcare Equipment and Supplies
Invalid Date
06/25/2015
NASDAQ Stock Exchange
808
12-31
Common stock
201 Burlington Road, South Building, Bedford, MA 01730
--
Lantheus Holdings, Inc., was founded in 2007 in Delaware and is headquartered in North Billerica, Massachusetts. The company is a global leader in the development, production, sales and distribution of innovative medical imaging diagnostic reagents and products to assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's reagents are commonly used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. Clinicians use the company's imaging agents and products through a range of imaging methods, including nuclear imaging, echocardiography and magnetic resonance imaging, or MRI. The Company believes that improved diagnostic information enables healthcare services to provide better detection and characterization, or to exclude diseases, which may result in improved patient conditions, reduced patient risk, and limited overall taxpayer costs and the healthcare system as a whole.